Repare Therapeutics' Series A Round

Repare Therapeutics raised a round of funding on June 22, 2017.

Repare Therapeutics is developing precision oncology drugs for patients that target specific vulnerabilities of tumor cells. The company's approach integrates insights from several fields of cell biol…

Articles about Repare Therapeutics' Series A Round: